William G. Chu

Learn More
PURPOSE After radical prostatectomy continence is commonly defined as no pads except a security pad or 0 to 1 pad. We evaluated the association of pad status and urinary quality of life to determine whether security and 1 pad status differ from pad-free status to better define 0 pads as the post-prostatectomy standard. MATERIALS AND METHODS A total of 500(More)
INTRODUCTION AND OBJECTIVES Caliceal leak after partial nephrectomy (PN) typically resolves with conservative management. However, persistent fistulae pose a formidable challenge that may require additional therapeutic actions. METHODS We describe a case of a patient with a solitary kidney who suffered a persistent urine leak following PN. A novel(More)
To evaluate the impact of the urologist’s experience in selecting active surveillance (AS) versus immediate treatment (IT) for low-risk prostate cancer. Men with low-risk prostate cancer were enrolled from March 2011 to August 2013 at 13 medical centers in Kaiser Permanente Southern California. The AS cohort was defined as men who had cT1-T2a stage prostate(More)
OBJECTIVE To determine if eliminating the prophylactic placement of a pelvic drain (PD) after robot-assisted radical prostatectomy (RARP) affects the incidence of early (90-day) postoperative adverse events. PATIENTS AND METHODS In this parallel-group, blinded, non-inferiority trial, we randomised patients planning to undergo RARP to one of two arms: no(More)
Indocyanine Green (ICG) is frequently used during urologic robotic procedures and is generally considered to be safe. However, there are reported cases of severe complications from ICG when used for non-urologic purposes. We present the first case to our knowledge of anaphylactic shock in response to intravenous ICG during a robotic partial nephrectomy.
Robotic-assisted total pelvic exenteration (TPE) can offer a minimally invasive approach to a major multi-organ operation. In this video, we summarize a stepwise approach to robotic TPE in a 70 year-old female Jehovah’s witness with a history of cervical cancer post-chemoradiation and radical hysterectomy who experienced local recurrence at the vaginal cuff(More)
  • 1